Neuromyelitis Optica Spectrum Disorder

DrugDrug NameDrug Description
DB01257EculizumabA recombinant humanized monoclonal antibody used to reduce the risk of hemolysis in paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS).
DrugDrug NameTargetType
DB01257EculizumabComplement C5target
DrugDrug NamePhaseStatusCount
DB00112Bevacizumab1Completed1
DB11850Ublituximab1Completed1
DB00188Bortezomib2Completed1
DB00028Immune Globulin Human2Completed1
DB00993Azathioprine2 / 3Completed1
DB00073Rituximab2 / 3Completed1
DB01257Eculizumab3Active Not Recruiting1
DB01257Eculizumab3Terminated1